IIM Ahmedabad, Novo Nordisk India partner to strengthen obesity care ecosystem
Novo Nordisk India
to strengthen the
obesity care
ecosystem in the country for five years till 2030.
The memorandum of understanding, inked on Tuesday, aims to strengthen the
healthcare ecosystem
in India through a multi-dimensional approach focused on non-communicable diseases (NCDs), especially obesity, the Indian Institute of Management Ahmedabad (IIMA) said in a statement.
"This collaboration with Novo Nordisk India brings together healthcare and public policy, two domains where data and research can enable lasting change. At IIMA, we aim to apply our academic rigour to generate actionable insights for policymakers, healthcare professionals, and communities tackling non-communicable diseases like obesity,"
IIM Ahmedabad
Director Professor Bharat Bhasker said.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Play War Thunder now for free
War Thunder
Play Now
Undo
As a part of this collaboration, Novo Nordisk India (NNIPL) and IIMA will co-develop and implement impactful programmes under three key pillars - Health System Capacity Building,
Policy Advocacy
, and Health Economics.
Novo Nordisk Managing Director India Vikrant Shrotriya said, "This collaboration with IIM Ahmedabad will jointly shape interventions that are research-backed, scalable, and sustainable. It is our firm belief that partnerships like these can bring lasting change and help improve health outcomes for millions".
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
5 hours ago
- Time of India
Have we found the solution to reversing aging in magic mushrooms? Scientists believe they're closer than ever
Researchers at Emory University have found that psilocin, the active metabolite of psilocybin, the hallucinogenic compound in magic mushrooms , can significantly extend lifespan and improve biological health in mice. The study, published this week in 'Nature Partner Journals: Aging', raises the tantalizing question: could psychedelic therapy offer more than just mental health benefits and actually delay aging in humans? From psychedelics to prolonged Life Explore courses from Top Institutes in Please select course: Select a Course Category Data Science Project Management Digital Marketing Data Science MBA CXO Degree Management Data Analytics Technology Leadership Operations Management Cybersecurity Healthcare MCA PGDM Others others Finance Product Management healthcare Design Thinking Public Policy Artificial Intelligence Skills you'll gain: Duration: 30 Weeks IIM Kozhikode SEPO - IIMK-AI for Senior Executives India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months E&ICT Academy, Indian Institute of Technology Guwahati CERT-IITG Prof Cert in DS & BA with GenAI India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months IIT Madras CERT-IITM Advanced Cert Prog in AI and ML India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months E&ICT Academy, Indian Institute of Technology Guwahati CERT-IITG Postgraduate Cert in AI and ML India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months IIM Kozhikode CERT-IIMK DABS India Starts on undefined Get Details The study's results are as striking as they are unexpected. Mice administered psilocybin lived nearly 30 percent longer than their untreated peers, and they aged more gracefully, too. Treated mice displayed fuller, healthier coats, fewer white hairs, and more physical mobility. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo In parallel lab tests, human skin and lung cells exposed to psilocin demonstrated a 50 percent increase in lifespan. These results, researchers say, suggest that psilocybin may act on cellular aging mechanisms at a foundational level. "Psilocybin doesn't just alter consciousness; it appears to alter cellular fate," said Dr. Louise Hecker, senior author of the study and former associate professor at Emory University. 'Even when administered late in life, psilocybin still extended survival and improved physical function, which is clinically meaningful for aging populations.' Live Events Dr. Hecker, now at Baylor College of Medicine, led the team that tracked the impact of monthly psilocybin treatments on 19-month-old mice, roughly equivalent to 60- to 65-year-old humans. Mice received an initial low dose of 5 milligrams of psilocybin, followed by 15 mg monthly for ten months. What did the study say? The study revealed that psilocybin doesn't simply slow aging; it appears to address the biological hallmarks of aging itself. Treated mice showed reduced oxidative stress, a key driver of age-related diseases, as well as preserved telomere length and improved DNA repair. Telomeres are the protective caps at the ends of chromosomes. As we age, they naturally shorten, increasing vulnerability to cancer, neurodegenerative conditions, and heart disease. Psilocin appears to protect these cellular structures, suggesting its potential as a broad-spectrum anti-aging agent. 'These mechanisms are fundamental to aging and disease,' Dr. Hecker noted. 'Psilocybin may be the first drug of its kind to act on all of them simultaneously.' Not just a longer life, a better one For Dr. Ali John Zarrabi, Director of Psychedelic Research in Emory's Department of Psychiatry and a co-investigator on the study, the implications go far beyond lifespan. 'As a palliative care physician, I often ask: what's the point of living longer if it's with more pain, more dependency, and less dignity?' Zarrabi said. 'What excited us is that these mice weren't just surviving longer, they were thriving. That suggests psilocybin could help promote healthy aging, not just extended aging.' The findings come amid growing global interest in anti-aging science. With the US anti-aging market now surpassing $500 million annually, the search for therapies that extend both life and vitality has become a high-stakes frontier of medical research. The study's release also follows a sobering report from KFF showing that US life expectancy, currently 78.4 years, lags significantly behind that of other developed nations. From 1980 to 2022, American lifespan increased by only 4.7 years, compared to a 7.9-year increase elsewhere. Beyond mental health Although psilocybin has gained attention primarily for its powerful effects on treatment-resistant depression, anxiety, and PTSD , this study is one of the first to examine its systemic effects on aging. 'Most cells in the human body express serotonin receptors ,' Hecker explained, 'which suggests that psilocybin could exert influence far beyond the brain.' This broad receptor presence may be why the compound had such wide-ranging impacts on both cell health and whole-body physiology. Zarrabi confirmed that Emory is actively participating in Phase II and III clinical trials for psilocybin-assisted therapy for depression. He now hopes this study will spark expanded research into psilocybin's potential anti-aging benefits in humans. "If psilocybin gets FDA approval for depression in 2027," he said, "it may pave the way for trials investigating whether improved mental health can lead to improved physical health, and even extended lifespan." What's Next? While the findings are promising, experts caution that much more research is needed before psilocybin can be considered a legitimate anti-aging treatment for humans. 'We're just scratching the surface,' said Zarrabi. 'What we need now are long-term human trials in aging populations to explore not only the safety, but the functional benefits of psilocybin as a systemic therapeutic.'
Time of India
16 hours ago
- Time of India
Primary responsibility of states: Govt on implementing passive euthanasia in healthcare system
Health being a state subject, it is the primary responsibility of the states and Union territories to implement passive euthanasia and living wills in the healthcare system by incorporating these into hospital protocols to ensure that medical professionals are trained to respect patients' end-of-life preferences , the government told Parliament on Tuesday. In a written response to a question in the Rajya Sabha, Union Health Minister J P Nadda said it is also the responsibility of the states to establish ethical safeguards , such as a mandatory review by a medical board in accordance with a Supreme Court judgment . Explore courses from Top Institutes in Please select course: Select a Course Category healthcare Finance Artificial Intelligence Product Management Cybersecurity MCA Design Thinking Digital Marketing Leadership Data Science Data Analytics Public Policy Technology others Data Science Management CXO MBA Project Management Degree Operations Management Others Healthcare PGDM Skills you'll gain: Duration: 11 Months IIM Lucknow CERT-IIML Healthcare Management India Starts on undefined Get Details Nadda's response came with respect to a question on the specific measures taken to implement and promote passive euthanasia and living wills in the healthcare system in light of the 2018 judgment of the apex court. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo He said in the judgment in Common Cause Vs Union of India , the Supreme Court laid down specific guidelines for executing advance directives and implementing passive euthanasia. The court, in Miscellaneous Application No. 1699 of 2019 in Common Cause Vs Union of India, relaxed these guidelines by simplifying the procedure for executing the same. Live Events These modifications aimed at making the process more accessible for terminally-ill patients to exercise their right to die with dignity by refusing life-prolonging treatment, the minister said. "Health" being a state subject, it is the primary responsibility of the states and Union territories to implement passive euthanasia and living wills in the healthcare system by incorporating these into hospital protocols to ensure that medical professionals are trained to respect patients' end-of-life preferences," Nadda said in his written response.
Time of India
a day ago
- Time of India
Dhankhar got many opportunities to serve country in various capacities: PM Modi
Prime Minister Narendra Modi on Tuesday wished Jagdeep Dhankhar , who has resigned as vice president on health grounds , good health, and said he got many opportunities to serve the country in various capacities. He said on X, "Shri Jagdeep Dhankhar Ji has got many opportunities to serve our country in various capacities, including as the Vice President of India . Wishing him good health." Explore courses from Top Institutes in Please select course: Select a Course Category Management Project Management Design Thinking Operations Management MBA PGDM Degree Data Science Public Policy Leadership CXO healthcare Data Analytics Product Management Finance Data Science Others Healthcare Artificial Intelligence others MCA Skills you'll gain: Duration: 9 Months IIM Calcutta CERT-IIMC APSPM India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months IIM Kozhikode CERT-IIMK General Management Programme India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months IIM Kozhikode CERT-IIMK General Management Programme India Starts on undefined Get Details In a sudden move, Dhankhar had on Monday evening resigned from his post citing medical reasons . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Join new Free to Play WWII MMO War Thunder War Thunder Play Now Undo In his resignation letter to President Droupadi Murmu , Dhankhar said he was stepping down with immediate effect to "prioritise health care". "To prioritise health care and abide by medical advice, I hereby resign as Vice President of India, effective immediately, in accordance with Article 67(a) of the Constitution," he said in the letter to the President.
